In our second quarter reporting, we have included total sales on a constant currency basis, a new non-GAAP measure. The most directly comparable GAAP measure to total sales on a constant currency basis is total sales. We believe constant currency information is useful in analyzing underlying trends in our business and the commercial performance of our products by eliminating the impact of highly volatile fluctuations in foreign currency markets and allows for period-to-period comparisons of our performance. For simplicity, we may elect to omit this information in future periods if we determine a lack of material impact. To present this information, current period performance for entities reporting in currencies other than U.S. dollars are converted to U.S. dollars at the exchange rate in effect during the last day of the prior comparable period.
Management believes that these non-GAAP financial measures provide investors with relevant period-to-period comparisons of our core operations using the same methodology that management employs in its review of the Company's operating results. These financial measures are not recognized terms under GAAP and should not be considered in isolation or as a substitute for a measure of financial performance prepared in accordance with GAAP.
These non-GAAP financial measures have limitations that should be considered before using these measures to evaluate a company's financial performance. These non-GAAP financial measures, as presented, may not be comparable to similarly titled measures of other companies due to varying methods of calculation. The financial statement tables that accompany this press release include a reconciliation of these non-GAAP financial measures to the most directly comparable GAAP financial measures.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to risks and uncertainties, such as statements about demand for and customer acceptance of FARO's products, FARO's product development and product launches, FARO's growth, strategic and restructuring plans and initiatives, including but not limited to the additional restructuring charges expected to be incurred in connection with our restructuring plan and the timing and amount of cost savings and other benefits expected to be realized from the restructuring plan and other strategic initiatives, and FARO's growth potential and profitability. Statements that are not historical facts or that describe the Company's plans, objectives, projections, expectations, assumptions, strategies, or goals are forward-looking statements. In addition, words such as "is," "will," "intend," "believe," "expect," "may," "could" or "should," and similar expressions or discussions of FARO's plans or other intentions identify forward-looking statements. Forward-looking statements are not guarantees of future performance and are subject to various known and unknown risks, uncertainties, and other factors that may cause actual results, performances, or achievements to differ materially from future results, performances, or achievements expressed or implied by such forward-looking statements. Consequently, undue reliance should not be placed on these forward-looking statements.
Factors that could cause actual results to differ materially from what is expressed or forecasted in such forward-looking statements include, but are not limited to:
- the Company's ability to realize the intended benefits of its undertaking to transition to a company that is reorganized around functions to improve the efficiency of its sales organization and to improve operational effectiveness;
- the Company's inability to successfully execute its new strategic plan and restructuring plan, including but not limited to additional impairment charges and/or higher than expected severance costs and exit costs, and its inability to realize the expected benefits of such plans;
- the outcome of the U.S. Government's review of, or investigation into, the GSA Matter; any resulting penalties, damages, or sanctions imposed on the Company and the outcome of any resulting litigation to which the Company may become a party; loss of future government sales; and potential impacts on customer and supplier relationships and the Company's reputation;
- development by others of new or improved products, processes or technologies that make the Company's products less competitive or obsolete;
- the Company's inability to maintain its technological advantage by developing new products and enhancing its existing products;
- declines or other adverse changes, or lack of improvement, in industries that the Company serves or the domestic and international economies in the regions of the world where the Company operates and other general economic, business, and financial conditions;
- the effect of the COVID-19 pandemic, including on our business operations, as well as its impact on general economic and financial market conditions;
- the impact of fluctuations in foreign exchange rates; and
- other risks detailed in Part I, Item 1A. Risk Factors in the Company's Annual Report on Form 10-K for the year ended December 31, 2021 filed with the SEC on February 16, 2022 and in our Quarterly Report on Form 10-Q for the quarter ended June 30, 2022 that will be filed with the SEC following this earnings release.
Forward-looking statements in this release represent the Company's judgment as of the date of this release. The Company undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events, or otherwise, unless otherwise required by law.
FARO TECHNOLOGIES, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) | |||||||
| |||||||
| Three Months Ended |
| Six Months Ended | ||||
(in thousands, except share and per share data) | June 30, 2022 |
| June 30, 2021 |
| June 30, 2022 |
| June 30, 2021 |
Sales |
|
|
|
|
|
|
|
Product | $ 59,702 |
| $ 60,275 |
| $ 116,432 |
| $ 114,910 |
Service | 20,215 |
| 21,835 |
| 40,141 |
| 43,531 |
Total sales | 79,917 |
| 82,110 |
| 156,573 |
| 158,441 |
Cost of sales |
|
|
|
|
|
|
|
Product | 28,169 |
| 25,455 |
| 52,504 |
| 50,259 |
Service | 11,311 |
| 11,173 |
| 22,607 |
| 22,293 |
Total cost of sales | 39,480 |
| 36,628 |
| 75,111 |
| 72,552 |
Gross profit | 40,437 |
| 45,482 |
| 81,462 |
| 85,889 |
Operating expenses |
|
|
|
|
|
|
|
Selling, general and administrative | 36,018 |
| 33,594 |
| 71,508 |
| 66,942 |
Research and development | 12,042 |
| 11,760 |
| 24,170 |
| 23,733 |
Restructuring costs | 1,333 |
| 779 |
| 1,932 |
| 2,303 |
Total operating expenses | 49,393 |
| 46,133 |
| 97,610 |
| 92,978 |
Loss from operations | (8,956) |
| (651) |
| (16,148) |
| (7,089) |
Other (income) expense |
|
|
|
|
|
|
|
Interest (income) expense, net | (12) |
| 39 |
| (4) |
| 49 |
Other (income) expense, net | (1,636) |
| 883 |
| (1,649) |
| (732) |
Loss before income tax benefit | (7,308) |
| (1,573) |
| (14,495) |
| (6,406) |
Income tax expense (benefit) | 1,266 |
| (397) |
| 3,766 |
| (2,009) |
Net loss | $ (8,574) |
| $ (1,176) |
| $ (18,261) |
| $ (4,397) |
Net loss per share - Basic | $ (0.47) |
| $ (0.06) |
| $ (1.00) |
| $ (0.24) |
Net loss per share - Diluted | $ (0.47) |
| $ (0.06) |
| $ (1.00) |
| $ (0.24) |
Weighted average shares - Basic | 18,266,747 |
| 18,161,110 |
| 18,267,783 |
| 18,133,368 |
Weighted average shares - Diluted | 18,266,747 |
| 18,161,110 |
| 18,267,783 |
| 18,133,368 |